Full Press Release Details
Convenience translation
Fresenius Medical Care AG
ISIN: DE0005785802 // WKN: 578580
ISIN: US3580291066 // CUSIP: 358029106
Announcement pursuant to section 248a sentence
1 of the German Stock Corporation Act (Aktiengesetz - AktG)
In accordance with section 248a sentence 1 AktG, we hereby announce
the following: The action for defective resolution (Beschlussm ngelklageverfahren) brought before the Regional Court of Nuremberg-F rth
(Landgericht N rnberg-F rth) (file number: 1 HK O 4610/23), in which individual shareholders of the Company had objected
to the resolution passed at the Extraordinary General Meeting of the Company on July 14, 2023 regarding the change of the Company's
legal form to that of a stock corporation, has been terminated. This proceeding had been combined as the leading proceeding with the action
for defective resolution initially initiated at the Regional Court of Frankfurt a.M. (Landgericht Frankfurt a.M.) under the then
file number 3-05 O 539/23, after the proceedings initiated at the Regional Court of Frankfurt a.M. had been referred to the Regional Court
The termination of the related proceeding before the District Court
of Nuremberg-F rth is based on the fact that all shareholders who had filed actions for rescission or nullity against the resolution
in question have withdrawn their actions. No agreements were concluded between the Company and the plaintiffs.
Hof, this December 2024
Fresenius Medical Care AG
The Management Board